{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:05:50Z","timestamp":1748441150632},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,3,15]]},"DOI":"10.2169\/internalmedicine.2221-23","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T22:11:28Z","timestamp":1690323088000},"page":"867-871","source":"Crossref","is-referenced-by-count":2,"title":["Histologically Proven Recurrent Synovitis after Nivolumab Treatment"],"prefix":"10.2169","volume":"63","author":[{"given":"Yuki","family":"Nakayama","sequence":"first","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ikuma","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Oba","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Ishiwata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Wake","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izuru","family":"Kitajima","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kinowaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takazawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamiko","family":"Takemura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rivellese F, Humby F, Bugatti S, et al. B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure. Arthritis Rheumatol 72: 714-725, 2020 May.","DOI":"10.1002\/art.41184"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Humby F, Bombardieri M, Manzo A, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6: e1, 2009.","DOI":"10.1371\/journal.pmed.0060001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yeo L, Toellner KM, Salmon M, et al. Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann Rheum Dis 70: 2022-2028, 2011.","DOI":"10.1136\/ard.2011.153312"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Harre U, Georgess D, Bang H, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122: 1791-1802, 2012.","DOI":"10.1172\/JCI60975"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Laurent L, Anquetil F, Clavel C, et al. IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies. Ann Rheum Dis 74: 1425-1431, 2015.","DOI":"10.1136\/annrheumdis-2013-204543"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350: 2572-2581, 2004.","DOI":"10.1056\/NEJMoa032534"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Naidoo J, Cappelli LC, Forde PM, et al. Inflammatory arthritis: a newly recognized adverse event of immune checkpoint blockade. Oncologist 22: 627-630, 2017 Jun.","DOI":"10.1634\/theoncologist.2016-0390"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Weber JS, D'Angelo SP, Minor D, et al. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol 16: 375-384, 2015.","DOI":"10.1016\/S1470-2045(15)70076-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Risbjerg RS, Hansen MV, S\u00f8rensen AS, Kragstrup TW. The effects of B cell depletion on immune related adverse events associated with immune checkpoint inhibition. Exp Hematol Oncol 9: 9, 2020.","DOI":"10.1186\/s40164-020-00167-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Jeurling S, Cappelli LC. Treatment of immune checkpoint inhibitor-induced inflammatory arthritis. Curr Opin Rheumatol 32: 315-320, 2020.","DOI":"10.1097\/BOR.0000000000000701"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ogawa Y, Ohtsuki M, Uzuki M, et al. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells. Arthritis Rheum 48: 3350-3358, 2003.","DOI":"10.1002\/art.11322"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tanaka K, Kuboki M, Koi S, Toyota S. Nivolumab for methotrexate-associated classic Hodgkin's lymphoma in a rheumatoid arthritis patient. Intern Med 59: 829-833, 2020.","DOI":"10.2169\/internalmedicine.3772-19"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zen Y, Yeh MM. Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury. Mod Pathol 31: 965-973, 2018.","DOI":"10.1038\/s41379-018-0013-y"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/6\/63_2221-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T03:31:46Z","timestamp":1710559906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/6\/63_2221-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2221-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"article-number":"2221-23"}}